
Sample Preparation Products For Next Generation Sequencing Market Report 2026
Global Outlook – By Type (Deoxyribonucleic Acid (DNA) Extraction Purification And Isolation Products, Ribonucleic Acid (RNA) Extraction Purification And Isolation Products, Panels, Exome Kits And Target Enrichment Products, Deoxyribonucleic Acid (DNA) Library Construction Or Preparation Products, Ribonucleic Acid (RNA)-sequencing (Seq) Transcriptome And Gene Expression Products, Small Ribonucleic Acid (RNA) Next Generation Sequencing Sample Preparation Products), By Therapeutic Area (Oncology, Infectious Diseases, Human Genetics Or Population Genetics), By Application (Biotechnology, Medical, Pharmaceutical, Other Applications) - Market Size, Trends, And Global Forecast 2026-2035
Sample Preparation Products For Next Generation Sequencing Market Overview
• Sample Preparation Products For Next Generation Sequencing market size has reached to $42.52 billion in 2025 • Expected to grow to $85.54 billion in 2030 at a compound annual growth rate (CAGR) of 14.9% • Growth Driver: Rising Demand For Precision Medicine Drives Growth Of Sample Preparation Products In Next-Generation Sequencing (NGS) • Market Trend: Innovation In Sample Preparation Products Enhanced DNA/RNA Sequencing • North America was the largest region in 2025.What Is Covered Under Sample Preparation Products For Next Generation Sequencing Market?
Sample preparation products for next-generation sequencing (NGS) are specialized tools and reagents used to process biological samples, such as deoxyribonucleic acid (DNA) or ribonucleic acid (RNA), before sequencing. These products ensure that the genetic material is properly extracted, purified, and fragmented to meet the requirements of NGS platforms. The main types of sample preparation products for next generation sequencing are deoxyribonucleic acid (DNA) extraction purification and isolation products, ribonucleic acid (RNA) extraction purification and isolation products, panels exome kits and other target enrichment products, deoxyribonucleic acid (DNA) library construction or preparation products, ribonucleic acid (RNA)-sequencing (SEQ) transcriptome and gene expression products, and small ribonucleic acid (RNA) next generation sequencing sample preparation products. DNA extraction, purification, and isolation products are designed to isolate DNA from biological samples such as blood, tissues, and cells. The therapeutic area includes oncology, infectious diseases, and human genetics or population genetics, and it is used in various applications such as biotechnology, medical, pharmaceuticals, and others.
What Is The Sample Preparation Products For Next Generation Sequencing Market Size and Share 2026?
The sample preparation products for next generation sequencing market size has grown rapidly in recent years. It will grow from $42.52 billion in 2025 to $49.01 billion in 2026 at a compound annual growth rate (CAGR) of 15.3%. The growth in the historic period can be attributed to expansion of genomics research activities, increased use of NGS in clinical research, availability of advanced extraction and library preparation kits, growth in oncology research applications, rising adoption of sequencing technologies.What Is The Sample Preparation Products For Next Generation Sequencing Market Growth Forecast?
The sample preparation products for next generation sequencing market size is expected to see rapid growth in the next few years. It will grow to $85.54 billion in 2030 at a compound annual growth rate (CAGR) of 14.9%. The growth in the forecast period can be attributed to increasing demand for precision medicine applications, expansion of clinical NGS diagnostics, rising investments in genomics research infrastructure, growing adoption of automation in laboratories, ongoing innovation in sequencing sample preparation technologies. Major trends in the forecast period include increasing adoption of automated sample preparation workflows, growing demand for high-throughput ngs sample processing, expansion of targeted sequencing panels, rising focus on workflow standardization, enhanced integration with ngs platforms.Global Sample Preparation Products For Next Generation Sequencing Market Segmentation
1) By Type: Deoxyribonucleic Acid (DNA) Extraction Purification And Isolation Products, Ribonucleic Acid (RNA) Extraction Purification And Isolation Products, Panels, Exome Kits And Target Enrichment Products, Deoxyribonucleic Acid (DNA) Library Construction Or Preparation Products, Ribonucleic Acid (RNA)-sequencing (Seq) Transcriptome And Gene Expression Products, Small Ribonucleic Acid (RNA) Next Generation Sequencing Sample Preparation Products 2) By Therapeutic Area: Oncology, Infectious Diseases, Human Genetics Or Population Genetics 3) By Application: Biotechnology, Medical, Pharmaceutical, Other Applications Subsegments: 1) By Deoxyribonucleic Acid (DNA) Extraction Purification And Isolation Products: DNA Extraction Kits, DNA Purification Reagents, Isolation Columns And Magnetic Beads 2) By Ribonucleic Acid (RNA) Extraction Purification And Isolation Products: RNA Extraction Kits, RNA Purification Reagents, Isolation Columns And Magnetic Beads 3) By Panels, Exome Kits, And Target Enrichment Products: Exome Enrichment Kits, Targeted Panels For Specific Genes, Custom Enrichment Solutions 4) By Deoxyribonucleic Acid (DNA) Library Construction Or Preparation Products: DNA Library Preparation Kits, Fragmentation And End Repair Kits, Adapter Ligation Kits 5) By Ribonucleic Acid (RNA)-Sequencing (Seq) Transcriptome And Gene Expression Products: RNA-Seq Library Preparation Kits, Quantification Reagents For RNA-Seq, Transcriptome Analysis Tools 6) By Small Ribonucleic Acid (RNA) Next Generation Sequencing Sample Preparation Products: Small RNA Library Preparation Kits, Mirna Extraction And Quantification Products, Small RNA Enrichment KitsWhat Is The Driver Of The Sample Preparation Products For Next Generation Sequencing Market?
The increasing demand for precision medicine is expected to propel the growth of sample preparation products for the next-generation sequencing market going forward. Personalized medicine, also known as precision medicine, is a medical approach that tailors treatment and healthcare strategies to individual patients based on their unique genetic, environmental, and lifestyle factors. The rising demand for precision medicine is due to the growing incidence of chronic conditions such as cancer, diabetes, and cardiovascular disorders. Sample preparation products for NGS are integral to the advancement of precision medicine. They enable the accurate and efficient analysis of genetic information, which is essential for developing targeted therapies and improving patient outcomes in personalized healthcare. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to six in 2022. Therefore, increasing demand for precision medicine is driving sample preparation products for the next generation sequencing market.Key Players In The Global Sample Preparation Products For Next Generation Sequencing Market
Major companies operating in the sample preparation products for next generation sequencing market are Merck & Co. Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG, Eurofins Scientific SE, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Eppendorf AG, Promega Corporation, Oxford Nanopore Technologies Ltd, Takara Bio Inc, New England Biolabs, Fluidigm Corporation, Pacific Biosciences of California Inc., Analytik Jena AG, SeraCare Life Sciences, Diagenode Inc., Zymo Research Corporation, Nugen Technologies Inc., Swift Biosciences Inc., Tecan Group Ltd.Global Sample Preparation Products For Next Generation Sequencing Market Trends and Insights
Major companies operating in the sample preparation products for the next-generation sequencing market are developing innovations such as next-generation sequencing to gain a competitive edge in the market. Next-generation sequencing (NGS) is a revolutionary technology used to determine the sequence of Next-generation sequencing (NGS) is a revolutionary technology used to determine the sequence of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA), enabling the analysis of genetic variation and the study of biological phenomena. For instance, in July 2023, QIAGEN N.V., a Germany-based provider of sample and assay technologies, introduced QIAseq Normalizer Kits. These kits offer researchers a fast, convenient, and cost-effective way to pool DNA libraries, ensuring high-quality results in NGS runs. The kits are compatible with QIAGEN's QIAseq library prep solutions and other DNA/RNA prep workflows for Illumina platforms.What Are Latest Mergers And Acquisitions In The Sample Preparation Products For Next Generation Sequencing Market?
In December 2023, PerkinElmer, a US-based technology company, acquired Covaris for an undisclosed amount. This acquisition will enable PerkinElmer to enhance its genomics solutions portfolio, offering more comprehensive tools for researchers in molecular biology and drug discovery, while improving efficiency and precision in sample preparation for NGS and other applications. Covaris is a US-based company that manufactures sample preparation products for next-generation sequencing (NGS), proteomics, and drug discovery applications.Regional Outlook
North America was the largest region in the sample preparation products for next generation sequencing (NGS) market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Sample Preparation Products For Next Generation Sequencing Market?
The sample preparation products for next generation sequencing market consists of sales of instruments, kits, reagents, and consumables. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Sample Preparation Products For Next Generation Sequencing Market Report 2026?
The sample preparation products for next generation sequencing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the sample preparation products for next generation sequencing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Sample Preparation Products For Next Generation Sequencing Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $49.01 billion |
| Revenue Forecast In 2035 | $85.54 billion |
| Growth Rate | CAGR of 15.3% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Type, Therapeutic Area, Application |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Merck & Co. Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG, Eurofins Scientific SE, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Eppendorf AG, Promega Corporation, Oxford Nanopore Technologies Ltd, Takara Bio Inc, New England Biolabs, Fluidigm Corporation, Pacific Biosciences of California Inc., Analytik Jena AG, SeraCare Life Sciences, Diagenode Inc., Zymo Research Corporation, Nugen Technologies Inc., Swift Biosciences Inc., Tecan Group Ltd. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
